Additionally, anthracycline-free carboplatin-containing chemotherapy may be a viable combination treatment, although the result did not reach statistical significance.
← all excerpts
The optimal neoadjuvant treatment strategy for HR+/HER2 + breast cancer: a network meta-analysis.
1
—
—